BLFS Q3 2021 Earnings — BioLife Solutions, Inc. Revenue & Financial Results | Market Cap Arena

BLFSBioLife Solutions, Inc.

$890M

Q3 2021 Earnings

Healthcare Medical - Instruments & Supplies

Income Statement

Revenue

$34M+199.7% YoY

Gross Profit

$9M26.4% margin

Operating Income

-$11M-33.0% margin

Net Income

$79,0000.2% margin

EPS (Diluted)

$0.00

QoQ Revenue Growth

+8.3%

Cash Flow

Operating Cash Flow

$2M

Free Cash Flow

-$329,000

Stock-Based Comp.

$5M

Balance Sheet

Total Assets

$559M

Total Liabilities

$70M

Stockholders' Equity

$489M

Cash & Equivalents

$75M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$34M	$11M	+199.7%
Gross Profit	$9M	$6M	+38.5%
Operating Income	-$11M	-$1M	-795.6%
Net Income	$79,000	-$1M	+107.0%

Revenue Segments

Rental Revenue

$11M99%

Service Revenue

$112,0001%